The role of T lymphocytes in cancer patients undergoing immunotherapy with autologous dendritic cells
/in Dendritic Cells, International Publications /von 2011-04-25 / Clin Med Insights Oncol 2011;5:107-15Dendritic cell based tumor vaccination in prostate and renal cell cancer: a systematic review and meta-analysis
/in Dendritic Cells, Hypernephroma, International Publications, Prostate Cancer /von 2011-04-20 / PLoS ONE 2011 Apr;6(4):e18801Optimizing DC vaccination by combination with oncolytic adenovirus coexpressing IL-12 and GM-CSF
/in Dendritic Cells, International Publications /von 2011-04-05 / Mol. Ther. 2011 Aug;19(8):1558-68Dendritic cells and cutaneous T-cell lymphomas
/in Dendritic Cells, International Publications, Malignant Lymphoma /von 2011-04-01 / G Ital Dermatol Venereol 2011 Apr;146(2):103-13Chronic myeloid leukemia lysate-loaded dendritic cells induce T-cell responses towards leukemia progenitor cells
/in Chronic Leukemia, Dendritic Cells, International Publications /von 2011-04-01 / Immunotherapy 2011 Apr;3(4):569-76Third generation dendritic cell vaccines for tumor immunotherapy
/in Dendritic Cells, International Publications /von 2011-03-25 / Eur. J. Cell Biol. 2012 Jan;91(1):53-8Targeting of IL-2 and GM-CSF immunocytokines to a tumor vaccine leads to increased anti-tumor activity
/in Dendritic Cells, International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2011-03-17 / Int. J. Oncol. 2011 Jun;38(6):1719-29hTERT mRNA dendritic cell vaccination: complete response in a pancreatic cancer patient associated with response against several hTERT epitopes
/in Dendritic Cells, International Publications /von 2011-03-02 / Cancer Immunol. Immunother. 2011 Jun;60(6):809-18Changes in peripheral blood level of regulatory T cells in patients with malignant melanoma during treatment with dendritic cell vaccination and low-dose IL-2
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2011-03-01 / Scand. J. Immunol. 2011 Mar;73(3):222-33IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de